Literature DB >> 8280150

Endotoxin protects the gastric mucosa against ulcerogenic stimuli.

K Tsuji1, A Uehara, S B Santos, M Namiki.   

Abstract

It is well-documented that large amounts of endotoxin produce hemorrhagic mucosal lesions in the stomach. To determine whether endotoxin, when injected at small doses, similarly exerts ulcerogenic actions, endotoxin (0.4-40 micrograms/kg) was injected into 24 hr-fasted rats. These small doses of endotoxin did not affect the integrity of the gastric mucosa. Unexpectedly, however, pretreatment with these minute amounts of endotoxin protected the gastric mucosa against various ulcerogenic stimuli such as stress, nonsteroidal anti-inflammatory drugs and ethanol. The anti-ulcer actions of endotoxin were not observed in endotoxin-insensitive animals (C3H/HeJ mice), thereby suggesting that endogenous cytokines such as interleukin-1 may mediate these protective actions. These findings stand in contrast to the toxic effect of endotoxin as an ulcerogen and indicate that endotoxin, albeit its term "toxin," may have a beneficial effect for the host.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280150     DOI: 10.1006/bbrc.1993.2622

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Effect of purified lipopolysaccharides from strains of Helicobacter pylori and Helicobacter felis on acid secretion in mouse gastric glands in vitro.

Authors:  I T Padol; A P Moran; R H Hunt
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Low endotoxemia prevents the reduction of gastric blood flow induced by NSAIDs: role of nitric oxide.

Authors:  Sara Calatayud; Amparo Canet; Regina Bello; Carlos Hernández; Miguel Martí; M Dolores Barrachina
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

3.  Roles of histamine receptors and oxyradicals in aggravation of acid-induced gastric haemorrhagic ulcers in endotoxaemic rats.

Authors:  C R Hung; D Z Hsu
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.